1. Histone H3K27me3 demethylases regulate human Th17 cell development and effector functions by impacting on metabolism
- Author
-
Henrik Oerum, Marc Feldmann, Morten Lindow, Stefan Terlecki-Zaniewicz, David Ahern, Udo Oppermann, Pal Mander, Paul Bowness, Jeroen Baardman, Brante P. Sampey, Menno P.J. de Winther, Susanna Obad, Henry Penn, Adam P. Cribbs, Rab K. Prinjha, Paul Wordsworth, Martin Philpott, Graduate School, Medical Biochemistry, ACS - Atherosclerosis & ischemic syndromes, and AII - Inflammatory diseases
- Subjects
0301 basic medicine ,Jumonji Domain-Containing Histone Demethylases ,medicine.medical_treatment ,Primary Cell Culture ,Down-Regulation ,Autoimmune Diseases ,Histones ,03 medical and health sciences ,Immunology and Inflammation ,0302 clinical medicine ,Single-cell analysis ,medicine ,Humans ,Spondylitis, Ankylosing ,RNA-Seq ,Epigenetics ,Th17 cells ,Transcription factor ,Cells, Cultured ,030304 developmental biology ,Histone Demethylases ,Histone demethylase ,Inflammation ,0303 health sciences ,Multidisciplinary ,biology ,Effector ,Interleukin-17 ,Cell Differentiation ,Benzazepines ,Biological Sciences ,Cell biology ,Chromatin ,Histone Code ,Pyrimidines ,030104 developmental biology ,Metabolism ,Histone ,Cytokine ,Mitochondrial biogenesis ,biology.protein ,Demethylase ,030217 neurology & neurosurgery ,Transcription Factors ,030215 immunology - Abstract
Significance T cells control many immune functions, with Th17 cells critical in regulating inflammation. Following activation, T cells undergo metabolic reprogramming and utilize glycolysis to increase the ATP availability. Epigenetic mechanisms controlling metabolic functions in T cells are currently not well-defined. Here, we establish an epigenetic link between the histone H3K27me3 demethylases KDM6A/B and the coordination of a metabolic response. Inhibition of KDM6A/B leads to global increases in the repressive H3K27me3 histone mark, resulting in down-regulation of key transcription factors, followed by metabolic reprogramming and anergy. This work suggests a critical role of H3K27 demethylase enzymes in maintaining Th17 functions by controlling metabolic switches. Short-term treatment with KDM6 enzyme inhibitors may be useful in the therapy of chronic inflammatory diseases., T helper (Th) cells are CD4+ effector T cells that play a critical role in immunity by shaping the inflammatory cytokine environment in a variety of physiological and pathological situations. Using a combined chemico-genetic approach, we identify histone H3K27 demethylases KDM6A and KDM6B as central regulators of human Th subsets. The prototypic KDM6 inhibitor GSK-J4 increases genome-wide levels of the repressive H3K27me3 chromatin mark and leads to suppression of the key transcription factor RORγt during Th17 differentiation. In mature Th17 cells, GSK-J4 induces an altered transcriptional program with a profound metabolic reprogramming and concomitant suppression of IL-17 cytokine levels and reduced proliferation. Single-cell analysis reveals a specific shift from highly inflammatory cell subsets toward a resting state upon demethylase inhibition. The root cause of the observed antiinflammatory phenotype in stimulated Th17 cells is reduced expression of key metabolic transcription factors, such as PPRC1. Overall, this leads to reduced mitochondrial biogenesis, resulting in a metabolic switch with concomitant antiinflammatory effects. These data are consistent with an effect of GSK-J4 on Th17 T cell differentiation pathways directly related to proliferation and include regulation of effector cytokine profiles. This suggests that inhibiting KDM6 demethylases may be an effective, even in the short term, therapeutic target for autoimmune diseases, including ankylosing spondylitis.
- Published
- 2019
- Full Text
- View/download PDF